Prediction of durable response upon treatment with immune checkpoint inhibitors in melanoma

被引：0
|
作者：
Persa, O. [1 ,2 ]
Helbig, D. [2 ]
Schlaak, M. [3 ]
Biedermann, T. [1 ]
Noh, K. [4 ]
机构：
[1] Tech Univ Munich, Dept Dermatol & Allergol, D-80802 Munich, Germany
[2] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany
[3] Charite Univ Med Berlin, Dept Dermatol & Venerol, Berlin, Germany
[4] Univ Cologne, Dept Pathol, Cologne, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2024年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P201
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study
    van Not, Olivier J.
    de Meza, Melissa M.
    van den Eertwegh, Alfons J. M.
    Haanen, John B.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    van Breeschoten, Jesper
    de Groot, Jan-Willem B.
    Hospers, Geke A. P.
    Ismail, Rawa K.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Roos S.
    Stevense-den Boer, Marion A. M.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Bonenkamp, Han J.
    Boers-Sonderen, Marye J.
    Blokx, Willeke A. M.
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn P. M.
    EUROPEAN JOURNAL OF CANCER, 2022, 167 : 70 - 80
  • [22] Immune Checkpoint Inhibitors in Melanoma: A Review of Pharmacokinetics and Exposure–Response Relationships
    Cyril Leven
    Maël Padelli
    Jean-Luc Carré
    Eric Bellissant
    Laurent Misery
    Clinical Pharmacokinetics, 2019, 58 : 1393 - 1405
  • [23] Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma
    Shi, Fuyan
    Zhang, Wenjing
    Yang, Yichen
    Yang, Yitao
    Zhao, Junyi
    Xie, Mengqi
    Sheng, Chao
    Wang, Suzhen
    Wang, Qinghua
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [24] Machine Learning Improves the Prediction of Responses to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Tabari, Azadeh
    Cox, Meredith
    D'Amore, Brian
    Mansur, Arian
    Dabbara, Harika
    Boland, Genevieve
    Gee, Michael S.
    Daye, Dania
    CANCERS, 2023, 15 (10)
  • [25] Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update
    Vukadin, Sonja
    Khaznadar, Farah
    Kizivat, Tomislav
    Vcev, Aleksandar
    Smolic, Martina
    BIOMEDICINES, 2021, 9 (07)
  • [26] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe NAmaria
    Christine Spencer
    Alexandre Reuben
    Zachary ACooper
    Jennifer AWargo
    Cancer Biology & Medicine, 2014, 11 (04) : 237 - 246+213
  • [27] Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanoma
    Spain, Lavinia
    Larkin, James
    IMMUNOTHERAPY, 2016, 8 (06) : 677 - 679
  • [28] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe N.Amaria
    Christine Spencer
    Alexandre Reuben
    Zachary A.Cooper
    Jennifer A.Wargo
    Cancer Biology & Medicine, 2014, (04) : 237 - 246
  • [29] Immune Checkpoint Inhibitors for Treatment of Metastatic Melanoma of the Orbit and Ocular Adnexa
    Ford, Joshua
    Thuro, Bradley A.
    Thakar, Sudip
    Hwu, Wen-Jen
    Richani, Karina
    Esmaeli, Bita
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (04): : E82 - E85
  • [30] Treatment beyond progression with immune checkpoint inhibitors in advanced melanoma.
    Sobczuk, Pawel
    Czarnecka, Anna Malgorzata
    Spalek, Mateusz
    Teterycz, Pawel
    Dudzisz-Sledz, Monika
    Switaj, Tomasz
    Rogala, Pawel
    Placzke, Joanna
    Kozak, Katarzyna
    Borkowska, Aneta
    Kosela-Paterczyk, Hanna
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345